Career development is a particularly important activity for translational research programs. By its verynature, translational research is multidisciplinary. Because of the depth of knowledge required of eachindividual discipline, our present educational structure seldom allows trainees to function in amultidisciplinary environment. This Career Development Awards Program is designed to provide theincentive and structure necessary to bring junior investigators into the multidisciplinary translational researcharena. The key to success of this endeavor is the availability and willingness of mentors throughout DF/HCCto meet the challenges of translational research. This Program will be led by Dr. Monica Bertagnolli,Program Director of the Feinberg Surgical Oncology Fellowship at Brigham and Women's Hospital and Co-Pi of the DF/HCC SPORE, and Dr. Robert Mayer, Vice-Chair for Academic Affairs at the Dana-FarberCancer Institute (DFCI) and Director of the DF/PCC Medical Oncology Fellowship. They are joined by acommittee including leaders in the fields of cancer therapeutics (Drs. Chabner and Schnipper), Gl cancersurgery (Drs. Warshaw and Zinner), tumor biology and genetics (Drs. Livingston, Kucherlapati, andPodolsky), cancer epidemiology (Dr. Willett), and women's health and health care disparities (Dr. Bigby).These outstanding senior mentors, representing BWH, MGH, DFCI, and BIDMC, will direct a program thatensure optimal selection, support, and oversight of the Gl SPORE Career Development Awards Program.
| Cao, Yin; Wu, Kana; Mehta, Raaj et al. (2018) Long-term use of antibiotics and risk of colorectal adenoma. Gut 67:672-678 |
| Barry, Joseph D; Fagny, Maud; Paulson, Joseph N et al. (2018) Histopathological Image QTL Discovery of Immune Infiltration Variants. iScience 5:80-89 |
| Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604 |
| Grasso, Catherine S; Giannakis, Marios; Wells, Daniel K et al. (2018) Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov 8:730-749 |
| Corcoran, Ryan B; André, Thierry; Atreya, Chloe E et al. (2018) Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer. Cancer Discov 8:428-443 |
| Song, Mingyang; Wu, Kana; Meyerhardt, Jeffrey A et al. (2018) Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol 4:71-79 |
| Babic, A; Schnure, N; Neupane, N P et al. (2018) Plasma inflammatory cytokines and survival of pancreatic cancer patients. Clin Transl Gastroenterol 9:145 |
| Lopes-Ramos, Camila M; Kuijjer, Marieke L; Ogino, Shuji et al. (2018) Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism. Cancer Res 78:5538-5547 |
| Van Blarigan, Erin L; Ou, Fang-Shu; Niedzwiecki, Donna et al. (2018) Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev 27:1227-1230 |
| Patra, Krushna C; Kato, Yasutaka; Mizukami, Yusuke et al. (2018) Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol 20:811-822 |
Showing the most recent 10 out of 590 publications
